Medicare for All would save nearly 20% on costs – notably decreases in administrative costs and pharmaceutical prices.
Kemp, et.al., 2019 This report was written by Eagan Kemp, health care policy advocate for Public Citizen’s Congress Watch division. Taylor Lincoln, research director for Congress Watch, provided guidance and aided in the collection and analysis of data. Susan Harley, deputy director of Public Citizen’s Congress Watch division, and Lisa Gilbert, vice president for legislative affairs, edited the report. Steve Knievel, advocate for Public Citizen’s Access to Medicines Program, and Michael Carome, director of Public Citizen’s Health Research Group, provided subject matter expertise and guidance. THE CASE FOR MEDICARE-FOR-ALL Public Citizen Feb 4 2019 https://www.citizen.org/wp-content/uploads/migration/the_case_for_medicare-for-all_-_february.pdf
Numerous studies have analyzed the prospective effectiveness of single-payer plans nationally and at the state level, as well as other universal coverage approaches. 15 Most of these studies found savings, to varying degrees. These findings are supported by the experiences of countries that already have universal health care and provide care more efficiently than the United States. 16 A recent study by the Political Economy Research Institute at the University of Massachusetts-Amherst found that Medicare-for-All could save nearly 20 percent versus our current system, with the largest sources of savings being increased administrative efficiency and significantly lower pharmaceutical prices.17 Even a recent study by a researcher at the Koch Brothers-funded Mercatus Center, reached conclusions on overall health spending that would result in $2 trillion in lower health care spending over a ten-year period starting in 2022. 18 However, previous studies have found even higher savings from administrative efficiency than were cited in that study.19